文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

瑞士医院内社区获得性SARS-CoV-2奥密克戎变异株感染与流感感染的结局比较

Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland.
PubMed 文献 · JAMA Netw Open · 2023-02-01
一句话结论在瑞士15家医院住院患者中,社区获得性SARS-CoV-2奥密克戎变异株感染较流感住院死亡风险显著升高(sdHR 1.54),ICU入住率相似。

该多中心前瞻性队列研究纳入瑞士15家医院5212例住院患者,其中3066例(58.8%)为社区获得性SARS-CoV-2奥密克戎变异株感染(2022年1月15日至3月15日入院),2146例(41.2%)为甲型或乙型流感感染(2018年1月1日至2022年3月15日入院)。主要结局为院内死亡,奥密克戎组7.0%(214例) vs 流感组4.4%(95例),校正后亚分布风险比(sdHR)1.54(95%CI 1.18-2.01;P=.002)。ICU入住率奥密克戎组8.6%(250例) vs 流感组8.3%(169例),校正后sdHR 1.08(95%CI 0.88-1.32;P=.50),无显著差异。作者认为奥密克戎变异株感染较流感住院死亡风险显著增加,而ICU入住率相似。

要点

  • 在15家瑞士医院5212例住院患者中,奥密克戎组院内死亡7.0%(214例) vs 流感组4.4%(95例),校正后sdHR 1.54(95%CI 1.18-2.01;P=.002)。
  • 奥密克戎组ICU入住8.6%(250例) vs 流感组8.3%(169例),校正后sdHR 1.08(95%CI 0.88-1.32;P=.50),无显著差异。
  • 奥密克戎组患者较流感组更年轻(中位年龄71岁 vs 74岁;P<.001),女性比例更低(48.4% vs 51.9%;P=.02)。
  • 研究采用Cox回归(原因特异性及Fine-Gray亚分布风险模型)处理时间依赖性和竞争事件,并用逆概率加权校正混杂,第30天右删失。

适用人群与场景

  • 纳入2018年1月1日至2022年3月15日住院的甲型或乙型流感感染患者,以及2022年1月15日至3月15日(B.1.1.529奥密克戎优势株占比>95%时期)住院的社区获得性SARS-CoV-2奥密克戎变异株感染患者,年龄≥18岁。
  • 研究在瑞士15家医院进行。
  • 2022年8月30日时无研究结局的患者作删失处理。

研究设计与关键结果

  • 研究类型为前瞻性多中心队列研究,纳入瑞士15家医院5212例住院患者:奥密克戎组3066例(58.8%,来自14个中心),流感组2146例(41.2%,来自14个中心)。
  • 奥密克戎组女性1485例(48.4%),流感组女性1113例(51.9%)(P=.02);奥密克戎组中位年龄71岁(IQR 53-82),流感组中位年龄74岁(IQR 59-83)(P<.001)。
  • 主要终点院内死亡:奥密克戎组214例(7.0%) vs 流感组95例(4.4%)(P<.001);校正后亚分布风险比(sdHR)1.54(95%CI 1.18-2.01;P=.002)。
  • 次要终点ICU入住:奥密克戎组250例(8.6%) vs 流感组169例(8.3%)(P=.79);校正后sdHR 1.08(95%CI 0.88-1.32;P=.50),无显著差异。

证据类型、等级与局限

  • 证据类型:前瞻性多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,社区获得性SARS-CoV-2奥密克戎变异株感染住院患者较流感住院患者院内死亡风险显著增加,而ICU入住率相似。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: With the ongoing COVID-19 pandemic, it is crucial to assess the current burden of disease of community-acquired SARS-CoV-2 Omicron variant in hospitalized patients to tailor appropriate public health policies. Comparisons with better-known seasonal influenza infections may facilitate such decisions.

OBJECTIVE: To compare the in-hospital outcomes of patients hospitalized with the SARS-CoV-2 Omicron variant with patients with influenza.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study was based on a national COVID-19 and influenza registry. Hospitalized patients aged 18 years and older with community-acquired SARS-CoV-2 Omicron variant infection who were admitted between January 15 and March 15, 2022 (when B.1.1.529 Omicron predominance was >95%), and hospitalized patients with influenza A or B infection from January 1, 2018, to March 15, 2022, where included. Patients without a study outcome by August 30, 2022, were censored. The study was conducted at 15 hospitals in Switzerland.

EXPOSURES: Community-acquired SARS-CoV-2 Omicron variant vs community-acquired seasonal influenza A or B.

MAIN OUTCOMES AND MEASURES: Primary and secondary outcomes were defined as in-hospital mortality and admission to the intensive care unit (ICU) for patients with the SARS-CoV-2 Omicron variant or influenza. Cox regression (cause-specific and Fine-Gray subdistribution hazard models) was used to account for time-dependency and competing events, with inverse probability weighting to adjust for confounders with right-censoring at day 30.

RESULTS: Of 5212 patients included from 15 hospitals, 3066 (58.8%) had SARS-CoV-2 Omicron variant infection in 14 centers and 2146 patients (41.2%) had influenza A or B in 14 centers. Of patients with the SARS-CoV-2 Omicron variant, 1485 (48.4%) were female, while 1113 patients with influenza (51.9%) were female (P = .02). Patients with the SARS-CoV-2 Omicron variant were younger (median [IQR] age, 71 [53-82] years) than those with influenza (median [IQR] age, 74 [59-83] years; P < .001). Overall, 214 patients with the SARS-CoV-2 Omicron variant (7.0%) died during hospitalization vs 95 patients with influenza (4.4%; P < .001). The final adjusted subdistribution hazard ratio (sdHR) for in-hospital death for SARS-CoV-2 Omicron variant vs influenza was 1.54 (95% CI, 1.18-2.01; P = .002). Overall, 250 patients with the SARS-CoV-2 Omicron variant (8.6%) vs 169 patients with influenza (8.3%) were admitted to the ICU (P = .79). After adjustment, the SARS-CoV-2 Omicron variant was not significantly associated with increased ICU admission vs influenza (sdHR, 1.08; 95% CI, 0.88-1.32; P = .50).

CONCLUSIONS AND RELEVANCE: The data from this prospective, multicenter cohort study suggest a significantly increased risk of in-hospital mortality for patients with the SARS-CoV-2 Omicron variant vs those with influenza, while ICU admission rates were similar.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Portmann L, de Kraker MEA, Fröhlich G, et al. Hospital Outcomes of Community-Acquired SARS-CoV-2 Omicron Variant Infection Compared With Influenza Infection in Switzerland. JAMA Netw Open. 2023. PMID: 36790812. doi:10.1001/jamanetworkopen.2022.55599

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。